Increasing evidence of recent studies revealed that the level of phosphoenolpyruvate (PEP), a metabolite downstream of PGAM1 and generated from 2PG in glycolysis, is significantly upregulated in tumor cells as compared to that from adjacent normal tissues (Chinnaiyan et al, 2012). This evidence concerns the gene PGAM1 and neoplasm.